Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference26 articles.
1. Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System;Balch;J Clin Oncol,2001
2. European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma;Eggermont;Semin Oncol,2002
3. Does adjuvant interferon-α for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials;Wheatley;Cancer Treat Rev,2003
4. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684;Kirkwood;J Clin Oncol,1996
5. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of Intergroup Trial E1690/S9111/C9190;Kirkwood;J Clin Oncol,2000
Cited by 562 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Breaking free from the inflammatory trap of depression: Regulating the interplay between immune activation and plasticity to foster mental health;Neuroscience Applied;2024
2. Promising and Minimally Invasive Biomarkers: Targeting Melanoma;Cells;2023-12-20
3. Pharmacological and neuroprotective effects of Helicid alleviates neuronal apoptosis of rats with depression-like behaviors by downregulating lncRNA-NONRATT030918.2;2023-11-30
4. Real-world relapse-free survival data on adjuvant anti-PD-1 therapy for patients with newly diagnosed and recurrent stage III melanoma;Melanoma Research;2023-11-28
5. Antitumor activity of pegylated human interferon β as monotherapy or in combination with immune checkpoint inhibitors via tumor growth inhibition and dendritic cell activation;Cellular Immunology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3